Clinical Trials Browser

Phase 1/2 × Carcinoma, Basal Cell × HhAntag691 × Clear all

NCT02690948 2019-03-08

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

Phase 1/2 Completed

16 enrolled 15 charts

Carcinoma, Basal Cell